Combination of Two Drugs Shows Promise in Treating B-Cell Acute Lymphoblastic Leukemia

In mice it is less toxic and more effective (ANSA)

Two young siblings diagnosed with leukaemia within six months

It was extremely rare for siblings to face the same leukaemia diagnosis and hearing the news twice had been this Wellington family’s worst nightmare.

Combination of two drugs shows promise in treating B-cell acute lymphoblastic leukemia

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.

Scientists develop new treatment with potential to tackle most common form of childhood cancer

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the most common cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.

Well the first tests of a more common cancer therapy in children - Global Happenings

Was experimented in the mice and in human cells grown in the laboratory one new therapy against the Most common tumor in childrenthe acute B type B lymphoblastic leukemia: provides for the combination of two drugs that lead to death the malignant cells, and promises to be a lot less toxic Compared to current therapies, which usually provide years of chemotherapy, and more effective for teenagers and adults, in which the results are often worse. …

Scientists develop new treatment with potential to tackle commonest form of childhood cancer - Scientific Inquirer

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists. Although the research has so far only been conducted in cell lines and mice, the team is seeking funding to begin clinical trials in patients shortly. More than 500 p…